Generics

Camber launches generic Toradol

Ketorolac tromethamine injection is indicated for the short-term management of moderately severe acute pain that requires analgesia at the opioid level.
Sandoz releases generic Abraxane

The single-dose 100mg vial for intravenous use is FDA approved for metastatic breast cancer.
FDA gives Alembic nod for generic Lastacaft

Alcaftadine ophthalmic solution, 0.25% is used to temporarily relieve itchy eyes due to allergens.
FDA approves Dong-A ST’s Stelara biosimilar

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
Biden administration releases preliminary list of $2 generic drugs for Medicare recipients

Participation in the model would be voluntary for Part D sponsors and, pending further development, could start as early as January 2027.
Teva’s Prolia biosimilar candidate accepted for review by FDA, EU EMA

Prolia is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal women.
Glenmark pays $25M to resolve alleged False Claims Act liability for drug price-fixing

The government alleged that between 2013 and 2015, Glenmark paid and received compensation prohibited by the Anti-Kickback Statute.
Camber touts 8 generic product launches in Q3-2024

The company launched several other generics during Q1 and Q2.

Viatris inks deal with Lexicon for sotagliflozin outside of U.S., Europe